Anti-inflammatory effect of Yu-Ping-Feng-San via TGF-β۱ signaling suppression in rat model of COPD

  • سال انتشار: 1395
  • محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 19، شماره: 9
  • کد COI اختصاصی: JR_IJBMS-19-9_011
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 147
دانلود فایل این مقاله

نویسندگان

Zhong-Shan Yang

Faculty of Basic Medical Science, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan

Jin-Yuan Yan

Central laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan

Ni-Ping Han

Faculty of Basic Medical Science, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan

Wei Zhou

Faculty of Basic Medical Science, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan

Yu Cheng

Faculty of Basic Medical Science, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan

Xiao-Mei Zhang

Faculty of Basic Medical Science, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan

Ning Li

Faculty of Basic Medical Science, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan

Jia-Li Yuan

Faculty of Basic Medical Science, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan

چکیده

Objective(s): Yu-Ping-Feng-San (YPFS) is a classical traditional Chinese medicine that is widely used for treatment of the diseases in respiratory systems, including chronic obstructive pulmonary disease (COPD) recognized as chronic inflammatory disease. However, the molecular mechanism remains unclear. Here we detected the factors involved in transforming growth factor beta ۱ (TGF-β۱)/Smad۲ signaling pathway and inflammatory cytokines, to clarify whether YPFS could attenuate inflammatory response dependent on TGF-β۱/Smad۲ signaling in COPD rats or cigarette smoke extract (CSE)-treated human bronchial epithelial (Beas-۲B) cells.  Materials and Methods: The COPD rat model was established by exposure to cigarette smoke and intratracheal instillation of lipopolysaccharide, YPFS was administered to the animals. The efficacy of YPFS was evaluated by comparing the severity of pulmonary pathological damage, pro-inflammation cytokines, collagen related genes and the activation of TGF-β۱/Smad۲ signaling pathway. Furthermore, CSE-treated cells were employed to confirm whether the effect of YPFS was dependent on the TGF-β۱/Smad۲ signaling via knockdown Smad۲ (Si-RNA), or pretreatment with the inhibitor of TGF-β۱. Results: Administration of YPFS effectively alleviated injury of lung, suppressed releasing of pro-inflammatory cytokines and collagen deposition in COPD animals (P< ۰.۰۵), whereas exogenous TGF-β۱ promoted releasing of IL-۱β, IL-۶, TNFα (P< ۰.۰۵). Administration YPFS reduced inflammatory response significantly, also down-regulated TGF-β۱/Smad۲ signaling in vivo and in vitro. Unexpectedly, knockdown Smad۲ or inhibition of TGF-β۱ abolished anti-inflammatory effect of YPFS in CSE-treated cells. Conclusion: YPFS accomplished anti-inflammatory effects mainly by suppressing phosphorylation of Smad۲, TGF-β۱/Smad۲ signaling pathway was required for YPFS-mediated anti-inflammation in COPD rats or CSE-treated Beas-۲B cells.

کلیدواژه ها

COPD, Pro-inflammatory, Cytokine, TGF-β۱/Smad۲, YPFS

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.